首页> 外文期刊>Nephrology nursing journal: journal of the American Nephrology Nurses’ Association >Clinical and cost effectiveness of guidelines to prevent intravascular catheter-related infections in patients on hemodialysis.
【24h】

Clinical and cost effectiveness of guidelines to prevent intravascular catheter-related infections in patients on hemodialysis.

机译:预防血液透析患者血管内导管相关感染的指南的临床和成本效益。

获取原文
获取原文并翻译 | 示例
           

摘要

Sepsis is the second leading cause of death in patients with end stage renal disease (ESRD) on hemodialysis (HD). The average cost to the healthcare system for catheter-related infections (CRI) ranges from $4000 to $80,235 for each occurrence. CRI is a significant health problem leading to increased hospitalizations, morbidity, mortality, and a financial burden to the healthcare system. The purpose of this study was to evaluate the clinical and cost effectiveness of implementing published guidelines that pertain to patients on HD. Adult patients receiving long-term HD through a tunneled and cuffed HD catheter in an outpatient dialysis setting were studied. One-hundred and eighty-seven patients on HD were instituted on published guidelines (chlorhexidine to clean the exit site and HD catheters/hubs, hand washing, aseptic technique with site/dressing changes/placing patients on HD, setting up an infrastructure to support monitoring CRI) and prospectively followed from May 2009 to April 2010. Comparison was made to a retrospective cohort of 198 patients on HD from May 2008 to April 2009 in the same unit using standard care (sodium hypochlorite to clean the exit site; povidone iodine to clean the HD catheter hubs). A t-test analysis compared the two groups for differences. The number of infections decreased from 1.7 to 0.2 per 1000 catheter days during a 12-month period (p = 0.005). The number needed to prevent one adverse outcome of a CRI was 22 patients, with a relative risk of 0.11 and relative risk reduction of 89% in the treated group. The return on investment for implementing the program was 169% in one year, and the break-even point occurred within the first quarter. The projected annual savings in one dialysis unit was $141,606 using the project hospital's data and $179,010 using national data. CRI in patients on HD are preventable. The analysis revealed a significant reduction in CRI by implementing published guidelines with a significant cost savings to the healthcare system.
机译:败血症是血液透析(HD)导致终末期肾脏疾病(ESRD)患者的第二大死亡原因。每次发生的医疗保健系统导管相关感染(CRI)的平均成本在4000美元到80235美元之间。 CRI是一个严重的健康问题,导致住院率,发病率,死亡率增加,并给医疗保健系统带来了财务负担。这项研究的目的是评估实施有关HD患者的已发布指南的临床和成本效益。研究了在门诊透析环境中通过隧道式和袖套式HD导管接受长期HD治疗的成年患者。根据已发布的指南,对187例HD患者进行了指导(洗必泰清洁出口部位和HD导管/枢纽,洗手,无菌技术以及部位/换药/将患者放置在HD上,建立了支持基础设施并于2009年5月至2010年4月进行了前瞻性随访。与2008年5月至2009年4月在同一病房使用标准护理(次氯酸钠清洁出口部位;聚维酮碘)的198例HD患者进行回顾性比较。清洁HD导管接头)。 T检验分析比较了两组的差异。在12个月内,感染的数量从每1000导管日1.7减少到0.2(p = 0.005)。预防CRI一项不良后果所需的人数为22名患者,治疗组的相对危险度为0.11,相对危险度降低了89%。实施该计划的投资回报率在一年内为169%,收支平衡点出现在第一季度之内。使用项目医院的数据,一个透析单元的预计年度节省为141,606美元,而使用全国性数据,则为179,010美元。 HD患者的CRI是可以预防的。分析显示,通过实施已发布的指南可显着降低CRI,同时可大大节省医疗保健系统的成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号